Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences
{{output}}
Antibody-drug conjugates (ADCs) are a recent, revolutionary approach for malignancies treatment, designed to provide superior efficacy and specific targeting of tumor cells, compared to systemic cytotoxic chemotherapy. Their structure combines highly potent an... ...